YLR285C-A Antibody

What is YLR285C-A and what cellular functions does it participate in?

YLR285C-A is a protein encoded in the Saccharomyces cerevisiae genome, specifically identified in the strain ATCC 204508/S288c. This protein is part of the systematic nomenclature used for yeast genes, where YLR indicates its location on chromosome XII, and 285C-A refers to its specific position and orientation within that chromosome. The protein is cataloged in the UniProt database under accession number Q3E771 . While detailed functional characterization information is limited in the provided search results, antibodies against this target are valuable for studying protein expression, localization, and interactions within yeast cellular systems. Researchers typically employ YLR285C-A antibodies in combination with other molecular tools to elucidate the protein's role in cellular pathways, stress responses, or metabolic functions relevant to fundamental biological processes in eukaryotic cells.

What detection methods are compatible with YLR285C-A antibody?

YLR285C-A antibody can be utilized across multiple detection platforms in research settings. The most common applications include Western blotting for protein expression quantification, immunoprecipitation for studying protein interactions, immunohistochemistry or immunofluorescence for cellular localization studies, and flow cytometry for analyzing expression in specific cell populations. The antibody (CSB-PA661642XA01SVG) is available in volumes suitable for these applications (2ml/0.1ml) . For optimal results, researchers should validate the antibody in their specific detection system, as performance may vary between applications. Particularly for low-abundance proteins like many yeast regulatory factors, signal amplification techniques may be necessary. Verification of specificity using appropriate controls, including knockout strains where the YLR285C-A gene has been deleted, is essential for ensuring result validity regardless of the detection method employed.

How should YLR285C-A antibody be stored to maintain optimal activity?

Proper storage conditions are crucial for maintaining antibody functionality and extending shelf-life. YLR285C-A antibody (CSB-PA661642XA01SVG) should be stored according to manufacturer recommendations to preserve its epitope recognition capacity . Generally, antibodies against yeast proteins require storage at -20°C for long-term preservation, with aliquoting recommended to avoid repeated freeze-thaw cycles that can degrade protein structure and reduce binding efficiency. Working dilutions can typically be stored at 4°C for up to one month. The addition of preservatives such as sodium azide (0.02%) to storage solutions can prevent microbial contamination, though researchers should verify this doesn't interfere with downstream applications. For particularly sensitive applications such as immunoprecipitation or chromatin immunoprecipitation, preserving antibody activity is especially critical. Regular validation of antibody performance using positive controls is recommended, particularly when using antibody from older lots or after extended storage periods.

How can YLR285C-A antibody be used in studying protein-protein interactions in yeast?

YLR285C-A antibody presents a valuable tool for investigating protein-protein interactions through techniques such as co-immunoprecipitation (Co-IP), proximity ligation assays (PLA), and pull-down assays. For Co-IP applications, researchers typically lyse yeast cells under non-denaturing conditions to preserve native protein complexes, then use the YLR285C-A antibody immobilized on protein A/G beads to capture the target protein along with its interaction partners . The resulting complexes can be analyzed through mass spectrometry to identify novel binding partners or through Western blotting to confirm suspected interactions. For validating interactions in situ, proximity ligation assays combine YLR285C-A antibody with antibodies against suspected interaction partners, generating fluorescent signals only when proteins are in close proximity. Cross-linking approaches prior to immunoprecipitation can capture transient interactions that might otherwise be missed. When designing such experiments, researchers should consider appropriate controls including IgG controls, reciprocal Co-IPs, and validation in genetic knockout strains to confirm specificity of the observed interactions.

What considerations should be made when using YLR285C-A antibody in chromatin immunoprecipitation (ChIP) studies?

Chromatin immunoprecipitation with YLR285C-A antibody requires careful optimization due to the technical challenges associated with yeast cell wall disruption and chromatin preparation. Researchers should first verify whether YLR285C-A is known or suspected to interact with DNA or chromatin-associated proteins before proceeding with ChIP protocols. If pursuing this application, crosslinking conditions must be optimized specifically for yeast cells, typically using 1-3% formaldehyde for 10-15 minutes . Cell wall digestion with zymolyase followed by sonication conditions must be carefully calibrated to achieve chromatin fragments of 200-500bp. The YLR285C-A antibody's specificity for chromatin-bound forms of the protein should be validated using appropriate controls, including input chromatin, IgG controls, and ideally a strain where YLR285C-A is epitope-tagged or deleted. ChIP-qPCR primer design should target suspected binding regions as well as negative control regions. For ChIP-seq applications, the immunoprecipitated material must yield sufficient quantities of DNA for library preparation, which may require protocol adaptations for potentially low-abundance chromatin factors.

How can YLR285C-A antibody be utilized in studying protein modifications and regulation?

Investigating post-translational modifications (PTMs) of YLR285C-A protein requires specialized approaches using modification-specific antibodies in conjunction with the standard YLR285C-A antibody. Researchers can employ immunoprecipitation with YLR285C-A antibody followed by immunoblotting with antibodies against specific modifications (phosphorylation, ubiquitination, SUMOylation, etc.) . Alternatively, mass spectrometry analysis of immunoprecipitated YLR285C-A can provide comprehensive PTM profiling. For studying regulation under different conditions, researchers can perform time-course experiments exposing yeast to various stressors, nutrient conditions, or cell cycle synchronization, followed by immunoblotting with YLR285C-A antibody to track expression changes. Combining these approaches with genetic manipulations (such as kinase/phosphatase deletions) can elucidate regulatory pathways. Quantitative approaches like multiple reaction monitoring mass spectrometry can be employed for absolute quantification of modified versus unmodified forms. When designing such experiments, consideration should be given to extraction conditions that preserve labile modifications, and appropriate controls including phosphatase treatment or mutation of putative modification sites should be included.

What are the optimal conditions for Western blotting with YLR285C-A antibody?

Western blotting with YLR285C-A antibody requires protocol optimization specific to this yeast protein target. Based on general practices for yeast protein detection, researchers should consider the following parameters: For sample preparation, mechanical disruption of yeast cells using glass beads in the presence of protease inhibitors is recommended, followed by clarification of lysates by centrifugation . Protein denaturation should be performed at 70°C rather than boiling to prevent aggregation of membrane-associated proteins. SDS-PAGE separation typically requires 10-15% acrylamide gels for optimal resolution of yeast proteins in this molecular weight range. For transfer, PVDF membranes generally provide better results than nitrocellulose for yeast proteins. Blocking with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature is standard practice. The YLR285C-A antibody should be diluted according to manufacturer recommendations, typically starting with 1:1000 for initial optimization. Overnight incubation at 4°C often yields cleaner results than shorter incubations at room temperature. Detection systems should be selected based on anticipated expression levels, with chemiluminescence offering greater sensitivity for low-abundance yeast proteins.

What controls should be included when validating YLR285C-A antibody specificity?

Rigorous validation of YLR285C-A antibody specificity is essential for generating reliable research data. A comprehensive validation approach should include several complementary controls. First, genetic controls comparing wild-type yeast to YLR285C-A deletion strains provide the most definitive specificity validation, as the antibody signal should be absent in the knockout strain . Second, competitive blocking experiments where the antibody is pre-incubated with purified recombinant YLR285C-A protein before application to samples can confirm epitope-specific binding. Third, peptide competition using the immunizing peptide can similarly verify specificity. Fourth, epitope-tagged versions of YLR285C-A can be detected in parallel with both the antibody in question and an antibody against the tag. Fifth, siRNA or degron-based depletion of YLR285C-A should result in proportional signal reduction. Additionally, signal correlation across multiple detection methods (western blot, immunofluorescence, etc.) increases confidence in antibody specificity. For publication-quality work, researchers should document at least three independent validation approaches to conclusively establish specificity.

What protein extraction methods are most effective for detecting YLR285C-A in yeast samples?

Efficient extraction of YLR285C-A from yeast requires consideration of protein localization, solubility, and abundance. The following extraction methods can be employed, with selection based on specific experimental needs:

Regardless of the extraction method, samples should be processed rapidly and kept cold throughout to minimize protein degradation . For membrane-associated proteins, addition of 0.5-1% non-ionic detergents (NP-40, Triton X-100) may be necessary. When targeting specifically nuclear or organellar pools of YLR285C-A, subcellular fractionation prior to extraction is recommended. Extraction efficiency should be verified by comparing different methods and quantifying recovery using spike-in controls if absolute quantification is required.

What are common issues encountered when using YLR285C-A antibody and how can they be resolved?

Researchers working with YLR285C-A antibody may encounter several technical challenges. High background in Western blots or immunostaining is a common issue, typically resolved by increasing blocking stringency (5% BSA instead of milk), extending blocking time, increasing wash durations, and optimizing antibody dilution through careful titration . Weak or absent signals may result from insufficient protein extraction, epitope masking, or protein degradation; this can be addressed by comparing multiple extraction methods, adjusting detergent concentrations, adding additional protease inhibitors, and testing different antigen retrieval methods for fixed samples. Non-specific bands in Western blots may indicate cross-reactivity with related proteins or degradation products; this requires careful validation using knockout controls and optimization of washing conditions. For immunoprecipitation applications, poor recovery may result from suboptimal lysis conditions or buffer incompatibility; testing different lysis buffers with varying salt and detergent concentrations can help resolve this issue. Inconsistent results between experiments often indicate antibody instability or variation in experimental conditions; thorough documentation of protocols and inclusion of positive controls in each experiment can improve reproducibility.

How can researchers determine the appropriate concentration of YLR285C-A antibody for different applications?

Determining optimal antibody concentration requires systematic titration for each application to balance specific signal with background. For Western blotting, researchers should prepare a dilution series (typically ranging from 1:250 to 1:2000) using consistent protein amounts from positive control samples . The optimal concentration provides clear specific bands with minimal background. For immunofluorescence, a similar titration approach is recommended (typically starting with 1:100 to 1:500 dilutions), evaluating signal-to-noise ratio across multiple fields. For immunoprecipitation, efficiency should be assessed by comparing the amount of target protein in input versus immunoprecipitated fractions across different antibody concentrations, typically testing 1-10 μg of antibody per sample. Chromatin immunoprecipitation applications often require higher antibody concentrations (2-10 μg per reaction) due to the complexity of chromatin and potential epitope masking. For all applications, researchers should include appropriate negative controls (secondary antibody only, isotype controls) to distinguish specific from non-specific signal. Documentation of optimal concentrations for each antibody lot is essential, as sensitivity may vary between lots or decline over time with repeated freeze-thaw cycles.

How does the choice of detection system affect the sensitivity when working with YLR285C-A antibody?

The detection system selected for use with YLR285C-A antibody significantly impacts experimental sensitivity, dynamic range, and quantification accuracy. For Western blotting applications, researchers can choose among several detection systems with distinct characteristics:

For immunofluorescence applications, signal amplification systems such as tyramide signal amplification can increase sensitivity by 10-100 fold compared to standard secondary antibodies, useful for detecting low-abundance yeast proteins . For flow cytometry, selecting fluorophores with minimal spectral overlap with yeast autofluorescence (avoiding FITC/GFP channels) improves signal discrimination. When multiple detection methods are available, researchers should consider the abundance of YLR285C-A in their specific system and select the detection method providing appropriate sensitivity while maintaining quantitative accuracy for their experimental questions.

How should researchers quantify and report YLR285C-A expression levels across different experimental conditions?

Accurate quantification of YLR285C-A expression requires rigorous analytical approaches and appropriate normalization. For Western blot quantification, researchers should capture images within the linear dynamic range of detection, avoid saturated signals, and use analysis software that integrates band intensity . Multiple normalization strategies should be employed, including loading controls (tubulin, actin, GAPDH) and total protein normalization methods like Ponceau S staining. When comparing expression across conditions, technical replicates (minimum of three) and biological replicates (typically three independent experiments) are essential for statistical validity. For reporting purposes, expression changes should be presented as fold-change relative to control conditions with appropriate statistical analyses (t-test, ANOVA) to establish significance. For immunofluorescence or flow cytometry quantification, single-cell measurements provide distribution data rather than population averages, which should be reported using both central tendency metrics and measures of population heterogeneity. Regardless of the method, researchers should clearly document all quantification parameters, software used, normalization strategies, and statistical approaches to ensure reproducibility.

What statistical approaches are appropriate for analyzing co-localization data involving YLR285C-A?

Co-localization analysis of YLR285C-A with other cellular components requires appropriate statistical methods beyond visual assessment. For microscopy-based co-localization studies, researchers should employ quantitative coefficients that measure spatial correlation between fluorescent signals . Pearson's correlation coefficient (PCC) measures the linear correlation between intensity values of the two channels, ranging from -1 (perfect negative correlation) to +1 (perfect positive correlation). Manders' overlap coefficient provides the proportion of YLR285C-A signal overlapping with the second marker, useful when protein distributions differ significantly. For object-based analyses, nearest-neighbor distances and object colocalization percentages provide quantitative measures suitable for punctate distributions typical of many yeast proteins. Statistical significance should be established through comparison with randomized controls generated by pixel shuffling or rotation of one channel relative to the other. For three-dimensional datasets from confocal microscopy, analysis should be performed on the entire 3D volume rather than maximum intensity projections to avoid artifacts. Researchers should report both the co-localization metrics and their statistical significance, along with representative images showing the original channels and merged views for visual confirmation.

How can researchers integrate YLR285C-A antibody data with other omics approaches for comprehensive functional analysis?

Integrating YLR285C-A antibody-generated data with multi-omics approaches provides comprehensive insights into protein function within cellular networks. Researchers can combine antibody-based detection of YLR285C-A with transcriptomics to correlate protein expression with mRNA levels, identifying potential post-transcriptional regulation mechanisms . Integration with proteomics data from mass spectrometry provides complementary protein identification, additional information on post-translational modifications, and potential validation of antibody specificity. Combining YLR285C-A localization data from immunofluorescence with metabolomics can reveal associations between protein localization and metabolic state. For network analysis, immunoprecipitation data identifying YLR285C-A interaction partners can be integrated with existing protein-protein interaction databases to position the protein within functional pathways. Data integration approaches include correlation analysis, machine learning classification methods, and network visualization tools. For meaningful integration, researchers should harmonize data formats, establish common identifiers across platforms, address missing values appropriately, and employ appropriate statistical methods for multi-dimensional data analysis. The integrated analysis should be visualized through pathway mapping, interaction networks, or multi-level heatmaps to communicate complex relationships effectively.